Authors: Moskowitz, CH Nimer, SD Zelenetz, AD Trippett, T Hedrick, EE Filippa, D Louie, D Gonzales, M Walits, J Coady-Lyons, N Qin, J Frank, R Bertino, JR Coy, A Noy, A O'Brien, JP Straus, D Portlock, CS Yahalom, J

Citation: Ch. Moskowitz et al., A 2-step comprehensive high-dose chemoradiotherapy second-line program forrelapsed and refractory Hodgkin disease: analysis by intent to treat and development of a prognostic model, BLOOD, 97(3), 2001, pp. 616-623

Authors: Kewalramani, T Zelenetz, AD Hedrick, EE Donnelly, GB Hunte, S Priovolos, AC Qin, J Lyons, NC Yahalom, J Nimer, SD Moskowitz, CH

Citation: T. Kewalramani et al., High-dose chemoradiotherapy and autologous stem cell transplantation for patients with primary refractory aggressive non-Hodgkin lymphoma: an intention-to-treat analysis, BLOOD, 96(7), 2000, pp. 2399-2404

Authors: Moskowitz, CH Bertino, JR Glassman, JR Hedrick, EE Hunte, S Coady-Lyons, N Agus, DB Goy, A Jurcic, J Noy, A O'Brien, J Portlock, CS Straus, DS Childs, B Frank, R Yahalom, J Filippa, D Louie, D Nimer, SD Zelenetz, AD

Citation: Ch. Moskowitz et al., Ifosfamide, carboplatin, and etoposide: A highly effective cytoreduction and peripheral-blood progenitor-cell mobilization regimen for transplant-eligible patients with non-Hodgkin's lymphoma, J CL ONCOL, 17(12), 1999, pp. 3776-3785